Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Enrolling by Invitation

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

NCT00102544

Conditions: Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +33 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Enrolling by Invitation

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

NCT06834204

Conditions: Adenocarcinoma, Bladder Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3), +40 more
Locations: Rutgers Cancer Institute New Brunswick, New Jersey, United States

View Trial Details

Enrolling by Invitation

Virtuoso Improving Anatomic Bladder Lesion Excision (VIABLE) Trial

NCT06940648

Conditions: Bladder Neoplasm, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Prince of Wales Hospital, Chinese University of Hong Kong Hong Kong

View Trial Details

Enrolling by Invitation

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

NCT07218003

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +54 more
Locations: UCSF Medical Center San Francisco, California, United States

Yale Cancer Center New Haven, Connecticut, United States

START Midwest Grand Rapids, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Enrolling by Invitation

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

NCT06885424

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +67 more
Locations: Banner Health Gilbert, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

NYU Langone Medical Center New York, United States

View Trial Details

Enrolling by Invitation

Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

NCT07488572

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Enrolling by Invitation

The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life

NCT05195515

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Department of Urology, Aarhus University Hospital Aarhus N, Denmark

Department of Urology, Regional Hospital Gødstrup Gødstrup, Denmark

Department of Urology, Regional Hospital Horsens Horsens, Denmark

Department of Urology, Regional Hospital Randers Randers, Denmark

View Trial Details

Enrolling by Invitation

Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review

NCT07307157

Conditions: Brain Cancer, Brain Diseases, Brain Neoplasms, +25 more
Locations: Harvard Medical School Boston, Massachusetts, United States

View Trial Details

Enrolling by Invitation

Use of Wearables Following Cystectomy- Part II

NCT07148765

Conditions: Bladder Cancer, Cystectomy, Female Urogenital Diseases, +16 more
Locations: UPMC Pittsburgh, Pennsylvania, United States

View Trial Details

Enrolling by Invitation

Information Needs and Supportive Rehabilitation Over Time in Patients Undergoing Cystectomy in Bladder Cancer

NCT07180121

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Department of Urology Linköping, Sweden

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions